Lose for Keeps
GLP-1s to kickstart your weight loss. Noom to make it last.
FIND YOUR PLANFSA & HSA eligible
Lose for Keeps
how it works
Medication handles the biology,
Noom handles the psychology.
Quiet the cravings
GLP-1s send signals to your brain that reduce appetite and decrease hunger. This quiets constant, exhausting food noise, opening a window for new habits to be built.
Build the habits
Once that window is open, shifting your mindset and building new habits becomes possible, leading to lasting change.
Keep it off
Maintain your weight loss with the healthy habits and mindset shifts you learn with Noom.
how it works
Medication handles the biology,
Noom handles the psychology.
The data
Noom’s approach delivers results
Most telehealth programs send you a prescription and call it a day. With Noom, our award-winning app is with you throughout — and built to maximize what your medication makes possible.
37%
more weight lost with Noom + GLP-1 than with medication alone.*
The part that lasts
And they’re your results, for Keeps
Not everyone's weight loss journey is linear. Life happens and circumstances can change, so building healthy habits you can keep is critical.
11 out of 12
GLP-1 users stop the medication within 3 years for various reasons.**
80%
That's the amount of weight Noom helps you keep off in the 6 months after stopping a GLP-1.***
One size fits all? Not with Noom.
Our clinical team offers a wide array of medications, making sure you get the treatment that’s best for you.
real noomers
Don’t just take it from us
FEATURED IN
Frequently Asked Questions
*Results based on a January 2026 analysis of 14,203 Noom GLP-1Rx Program members who actively logged weight over a 40 week period. High and low engagement groupings measured by quantile of app opens. Higher app engagement was associated with greater weight loss at 16 weeks; this association does not imply causation.
**Urick, Marshall and Gleason: GLP-1 Therapy to Treat Obesity Among Members Without Diabetes: Three-Year Persistence and Year-Over-Year Persistence Rate Change (June 25, 2025), https://www.primetherapeutics.com/documents/d/primetherapeutics/prime-therapeutics_glp-1-therapy-to-treat-obesity-among-members-without-diabetes_three-year-persistence .
***Based on a survey analysis of 169 GLP-1Rx users who stopped using a GLP-1 medication in the past 3-12 months. Users retained 78% of their weight lost.